These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18779424)

  • 1. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease.
    Brickman AM; Honig LS; Scarmeas N; Tatarina O; Sanders L; Albert MS; Brandt J; Blacker D; Stern Y
    Arch Neurol; 2008 Sep; 65(9):1202-8. PubMed ID: 18779424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.
    Mungas D; Reed BR; Jagust WJ; DeCarli C; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2002 Sep; 59(6):867-73. PubMed ID: 12297568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
    Prasad K; Wiryasaputra L; Ng A; Kandiah N
    Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
    Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
    J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.
    Tosto G; Zimmerman ME; Carmichael OT; Brickman AM;
    JAMA Neurol; 2014 Jul; 71(7):872-7. PubMed ID: 24821476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment risk: white matter hyperintensity progression matters.
    Silbert LC; Howieson DB; Dodge H; Kaye JA
    Neurology; 2009 Jul; 73(2):120-5. PubMed ID: 19597134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbleeds do not affect rate of cognitive decline in Alzheimer disease.
    van der Vlies AE; Goos JD; Barkhof F; Scheltens P; van der Flier WM
    Neurology; 2012 Aug; 79(8):763-9. PubMed ID: 22875093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for cognitive decline in patients with confluent white matter hyperintensities.
    Mok V; Xiong Y; Wong KK; Wong A; Schmidt R; Chu WW; Hu X; Lung Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S96-S103. PubMed ID: 22651941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up.
    Huang CW; Chang WN; Lui CC; Chen CF; Lu CH; Wang YL; Chen C; Juang YY; Lin YT; Tu MC; Chang CC
    Curr Alzheimer Res; 2010 Sep; 7(6):527-33. PubMed ID: 20455861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?
    Brickman AM; Muraskin J; Zimmerman ME
    Dialogues Clin Neurosci; 2009; 11(2):181-90. PubMed ID: 19585953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.